Departed
Jay Clayton
Chair and Lead Independent Director
APO ·
Apollo Global Management, Inc.
his resignation from the AGM Board will be effective as of April 21, 2025.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7251–7300 of 76368
Appointed
Marc Rowan
Chair of the Board
APO ·
Apollo Global Management, Inc.
appointed Mr. Marc Rowan, Chief Executive Officer of AGM, to serve as Chair of the Board, effective as of April 21, 2025.
Appointed
Gary Cohn
Lead Independent Director
APO ·
Apollo Global Management, Inc.
Mr. Gary Cohn will serve as Lead Independent Director of the Board of Directors (the “Board”) of Apollo Global Management, Inc. (“AGM”), effective as of April 21, 2025
Departed
Richard Parisi
Director
ContextLogic Inc.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
Departed
Elizabeth LaPuma
Director
ContextLogic Inc.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
Appointed
Michael Grissinger
Director
ACET ·
Adicet Bio, Inc.
On April 16, 2025, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Michael Grissinger to the Board, effective as of April 17, 2025, to fill the vacancy resulting from Dr. Gordon’s resignation.
Departed
Carl L. Gordon
Director
ACET ·
Adicet Bio, Inc.
On April 14, 2025, Carl L. Gordon, Ph.D., a Class II member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Compensation Committee of the Board (the “Compensation Committee”), effective on April 17, 2025.
Departed
D. Gary Gilliland
member of the board of directors
NUVL ·
Nuvalent, Inc.
On April 11, 2025, D. Gary Gilliland, M.D., Ph.D., a member of the board of directors (the “Board”) of Nuvalent, Inc. (the “Company”), notified the Company of his decision to resign from the Board and from all committees of the Board on which he serves, effective as of the date and time of the Company’s 2025 annual meeting of stockholders.
Departed
Timothy Haley
director
NFLX ·
NETFLIX INC
On April 11, 2025, Timothy Haley informed the Company of his decision to not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).
Role change
Reed Hastings
Chairman of the board of directors
NFLX ·
NETFLIX INC
Effective April 17, 2025, Reed Hastings will transition to serve as Chairman of the board of directors of the Company (the “Board”) and non-executive director.
Departed
Jennifer Banner
Director
Uniti Group Inc.
Current director Jennifer Banner will not stand for re-election at, and her current term as a director will end, at the Annual Meeting.
Appointed
Harold Zeitz
Director
Uniti Group Inc.
On April 16, 2025, the Board, on the recommendation of the Governance Committee of the Board, nominated Harold Zeitz for election to the Board as an independent director at the 2025 annual meeting of stockholders.
Departed
Gary P. Fayard
Director
MNST ·
Monster Beverage Corp
On April 14, 2025, Gary P. Fayard, currently a director on the Board of Directors (the “Board”) of Monster Beverage Corporation (the “Company”), provided notice to the Board and management of the Company of his intention not to stand for reelection at the 2025 Annual Meeting of the Stockholders (the “2025 Annual Meeting”).
Departed
J. Drayton Wise
Chief Commercial Officer
INSM ·
INSMED Inc
On April 16, 2025, J. Drayton Wise notified Insmed Incorporated (the “Company”) of his decision to resign from his position as the Company’s Chief Commercial Officer for personal and medical reasons, effective immediately.
Appointed
Gerald Cummins
Chief Compliance Officer
PFLT ·
PennantPark Floating Rate Capital Ltd.
Effective April 15, 2025, the board of directors of the Company appointed Gerald Cummins to replace Mr. Galea as the Company’s Chief Compliance Officer.
Departed
Frank Galea
Chief Compliance Officer
PFLT ·
PennantPark Floating Rate Capital Ltd.
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Floating Rate Capital Ltd. (the “Company”).
Departed
Frank Galea
Chief Compliance Officer
PNNT ·
PENNANTPARK INVESTMENT CORP
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Investment Corporation (the “Company”).
Appointed
Gerald Cummins
Chief Compliance Officer
PNNT ·
PENNANTPARK INVESTMENT CORP
Effective April 15, 2025, the board of directors of the Company appointed Gerald Cummins to replace Mr. Galea as the Company’s Chief Compliance Officer.
Appointed
Howard H. Berman
Class III director
AVIR ·
Atea Pharmaceuticals, Inc.
On April 16, 2025, the Board appointed Howard H. Berman, Ph.D. as a Class III director of the Company, effective at the Effective Time.
Departed
Franklin Berger
Class I director
AVIR ·
Atea Pharmaceuticals, Inc.
In addition, on April 16, 2025, in connection with the Agreement, Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.
Departed
John D. Buck
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Jody H. Feragen
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Pamela J. Tomczik
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Appointed
Kevin M. Barry
Director
PATTERSON COMPANIES, INC.
In addition, Kevin M. Barry was appointed as a director of the Company immediately following the Effective Time.
Departed
Philip G.J. McKoy
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Alex N. Blanco
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Robert C. Frenzel
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Meenu Agarwal
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Neil A. Schrimsher
Director
PATTERSON COMPANIES, INC.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Departed
Charles Watts, M.D.
Director
BDSX ·
BIODESIX INC
On April 15, 2025, Charles Watts, M.D., a member of the Board of Directors (the “Board”) of Biodesix, Inc. (the “Company”), notified the Company of his intention to resign from his position as a director of the Board and as a member of the Compensation Committee, effective at the conclusion of the Company’s 2025 Annual Meeting of Stockholders on May 20, 2025.
Departed
Christopher R. Delaney
President, Europe, Middle East and Africa
GT ·
GOODYEAR TIRE & RUBBER CO /OH/
Christopher R. Delaney, a named executive officer in the 2025 proxy statement, left his employment with The Goodyear Tire & Rubber Company (the “Company”) effective on April 14, 2025.
Appointed
Adele Gulfo
Director
NAMS ·
NewAmsterdam Pharma Co N.V.
On April 15, 2025, the board of directors (the “Board”) of NewAmsterdam Pharma Company N.V. (the “Company”) appointed Adele Gulfo to serve as a member of the Board.
Departed
Lynn Liang
Director
HIT ·
Health In Tech, Inc.
On April 12, 2025, Lynn Liang notified the Board of Directors (the “Board”) of Health In Tech, Inc., a Nevada corporation (the “Company”) that she is resigning from the Board effective April 18, 2025.
Appointed
William (Chip) Clark
Director
ALDX ·
Aldeyra Therapeutics, Inc.
the Board elected William (Chip) Clark as a Class I director
Appointed
Colin J. Kilrain
director
LGL ·
LGL GROUP INC
On April 16, 2025, the Board of Directors (the "Board") of LGL Group appointed Vice Admiral Colin J. Kilrain, USN (Ret.), as a director of the Company, effective immediately, to serve until the Company's next annual meeting of stockholders or until his successor is duly elected and qualified.
Departed
Michael Hansen
Director
WSBF ·
Waterstone Financial, Inc.
On April 17, 2025, Waterstone Financial, Inc. (the “Company”), announced today that Michael Hansen has decided to retire as a Director of the Company and its wholly-owned subsidiary WaterStone Bank SSB.
Appointed
Marc Boroditsky
Class I director
ASAN ·
Asana, Inc.
On April 16, 2025 the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) appointed Marc Boroditsky to serve on the Board as a Class I director, effective as of April 16, 2025.
Appointed
James C. Forbes
Director
INTERNET SCIENCES INC.
On April 14, 2025, the majority shareholders of the Corporation elected James C. Ford to serve as a member of the Board of Directors of the Corporation, effective May 1, 2025.
Departed
Brandon Romanek
Director
THC Therapeutics, Inc.
On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.
Departed
Edgard Corrales
Vice President, Explorations
SCCO ·
SOUTHERN COPPER CORP/
Mr. Corrales assumed a new role within Southern Peru Copper Corporation, Sucursal del Perú as the Advising Director of New Projects effective April 10, 2025.
Appointed
Juan Fernando Nuñez Chávez
Vice President, Explorations
SCCO ·
SOUTHERN COPPER CORP/
On April 10, 2025, the Board of Directors of Southern Copper Corporation (“SCC” or the “Company”) appointed Mr. Juan Fernando Nuñez Chávez as the Company’s Vice President, Explorations to replace Mr. Edgard Corrales.
Role change
Alan Connolly
Director of Strategic Finance
CRH ·
CRH PUBLIC LTD CO
Alan Connolly, CRH’s Interim Chief Financial Officer, will continue in that role until May 11, 2025, following which Mr. Connolly will return to his previous role with CRH as Director of Strategic Finance.
Appointed
Nancy Buese
Chief Financial Officer
CRH ·
CRH PUBLIC LTD CO
On April 17, 2025, CRH public limited company (‘CRH’ or the ‘Company’) announced the appointment of Nancy Buese as Chief Financial Officer, effective as of May 12, 2025.
Departed
Todd L. Capitani
Chief Financial Officer
SHBI ·
SHORE BANCSHARES INC
Todd L. Capitani, the Company’s current Chief Financial Officer, who previously announced his retirement, will continue with the Company until August 15, 2025 to support this leadership transition.
Appointed
Charles S. Cullum
Executive Vice President and Chief Financial Officer
SHBI ·
SHORE BANCSHARES INC
On April 17, 2025 , Shore Bancshares, Inc. (the “Company”) announced that it appointed Charles S. Cullum to Executive Vice President and Chief Financial Officer effective April 21, 2025.
Departed
Rossann Williams
Chief Operating Officer
SG ·
Sweetgreen, Inc.
On April 16, 2025, Sweetgreen, Inc. (the “Company”) and Rossann Williams, the Company’s Chief Operating Officer, mutually agreed that Ms. Williams would leave her employment with the Company, effective immediately.
Role change
Rebecca Taub
Senior Scientific and Medical Advisor
MDGL ·
MADRIGAL PHARMACEUTICALS, INC.
Pursuant to the Letter Agreement, effective as of April 21, 2025, Dr. Taub will transition from her current role and responsibilities to a new role as a Senior Scientific and Medical Advisor to the Company through the end of 2025.
Appointed
Cyril Wallace
Director
REED ·
REED'S, INC.
On May 16, 2025, the Company appointed Cyril Wallace, the Company’s Chief Executive Officer, to the Company’s board of directors.
Departed
Norman E. Snyder
Chief Executive Officer and Director
REED ·
REED'S, INC.
The disclosures set forth in Item 1.01 regarding Norman E. Snyder’s retirement and resignation from the positions of Chief Executive Officer and director and the terms of the Transition Agreement are incorporated into this section (b) by this reference.
Appointed
Cyril Wallace
Chief Executive Officer
REED ·
REED'S, INC.
The disclosures set forth in Item 1.01 regarding Cyril Wallace’s appointment as Chief Executive Officer and the terms of the Employment Agreement are incorporated into this section (c) by this reference.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.